EU approves contentious Alzheimer's medication

The European Union on Thursday approved the highly contentious Alzheimer’s medication Kisunla under strict conditions, with the drug’s effectiveness hotly debated by the medical community. “The European Commission has granted EU marketing authorisation for Kisunla, a medicine to treat mild

AFP

Latest news today on European Union

EU approves contentious Alzheimer's medication

EU commits fresh €250,000 aid to IDPs in Benue, Plateau

EU, Germany, FG host GET.invest inaugural Steering Committee meeting

EU, editors partner to raise awareness on impacts of fake news

EU, FG call for urgent action, domestic funding to address malnutrition

EU policies drag Europe’s 5G deployment

EU delays retaliatory trade tariffs against U.S.

Nigeria lagging behind in women representation, EU tells reps

104 Nigerians get EU-funded postgraduate scholarship

EU-funded project developing tool to boost food production

Empowering women, girls key to national prosperity, says EU ambassador

EU commits €110m to peace, security projects in ECOWAS

Russia shows readiness to assist Nigerian business community with contacts

EU reaffirms commitment to supporting Nigeria’s local dairy farmers

EU gives €1m to boost social protection in Nigeria

EU to invest €300m on digital, renewable energy, others in Northern Nigeria

EU to invests €300 million on digital, renewable energy in North

Mauritius deep in corruption scandal

Weaponising tariffs: Existential threats confronting global free trade

Traders lament N500m losses in Mowe-Ofada market demolition

France, Spain and the risk of treating World Cup odds as certainty

VAR, cables & red cards: Why World Cup needs clearer trust before its biggest matches

PFIPC scandal: Adeyemi alleges threat to life, begs Tinubu for independent probe

The News You Need, Delivered To You.